British Journal of Pharmacology

Article	Citations
Issue Information	477
	363
Issue Information	280
	277
Issue Information	185
Correction to “Melatonin epigenetic potential on testicular functions and fertility profile in varicocele rat model is mediated by silent information regulator 1”	170
	157
Structure–activity relationship of the allosteric effects of ivermectin at human P2X4 and GABAA receptors	152
A small molecule CFTR potentiator restores ATP‐dependent channel gating to the cystic fibrosis mutant G551D‐CFTR	151
Gβγ subunit signalling underlies neuropeptide Y‐stimulated vasoconstriction in rat mesenteric and coronary arteries	132
	132
Influx of kynurenine into the brain is involved in the reduction of ethanol consumption induced by Ro 61‐8048 after chronic intermittent ethanol in mice	131
Exploring pharmacological inhibition of Gq/11 as an analgesic strategy	100
A new class of 5‐HT2A/5‐HT2C receptor inverse agonists: Synthesis, molecular modeling, in vitro and in vivo pharmacology of novel 2‐aminotetralins	98
Chemosensory signalling in human sperm is controlled by Ca2+ influx via CatSper and Ca2+ clearance via plasma membrane Ca2+ ATPases	97
EXPRESSION OF CONCERN: Nitropravastatin Stimulates Reparative Neovascularisation and Improves Recovery from Limb Ischaemia in Type‐1 Diabetic Mice	93
Correction to ‘Stabilisation of PRCP by deubiquitinase‐targeting chimera (DUBTAC) to replenish autophagy for ameliorating pathological cardiac hypertrophy’	92
Biphasic effect of nicotine on glutamatergic activity in male mouse brain	88
Allosterism in the adenosine A2A and cannabinoid CB2 heteromer	86
The potential for biased signalling in the P2Y receptor family of GPCRs	75
Novel therapeutic approaches to target neurodegeneration	72
Pharmacokinetics and cardioprotective efficacy of intravenous miR‐125b* microRNA mimic in a mouse model of acute myocardial infarction	67
P2X2 receptor subunit interfaces are missense variant hotspots, where mutations tend to increase apparent ATP affinity	67
6‴‐Feruloylspinosin ameliorates pressure overload‐induced heart failure with comorbid insomnia through the activation of RORα	64
Identification of active ingredients from Lamiophlomis rotata that increase wound repair in mouse skin	59

Dual action of macrophage miR‐204 confines cyclosporine A‐induced atherosclerosis	58
Clinical‐data‐driven pharmacological framework in liver disease: From liver cirrhosis to hepatocellular carcinoma	57
Combined therapy with pirfenidone and nintedanib counteracts fibrotic silicosis in mice	52
Graph‐based algorithms to dissect long‐distance water‐mediated H‐bond networks for conformational couplings in GPCRs	51
Mas‐related G protein‐coupled receptors in gastrointestinal dysfunction and inflammatory bowel disease: A review	51
The fast‐dissociating D2 antagonist antipsychotic JNJ‐37822681 is a neuronal Kv7 channel opener: Potential repurposing for epilepsy treatment	50
Opportunities of patient‐derived organoids in drug development	49
Palbociclib blocks neutrophilic phosphatidylinositol 3‐kinase activity to alleviate psoriasiform dermatitis	49
Chronic stress induces behavioural changes through increased kynurenic acid by downregulation of kynurenine‐3‐monooxygenase with microglial decline	48
Integrating novel immunotherapeutic approaches in organ‐preserving therapies for bladder cancer	47
The respiratory depressant effects of mitragynine are limited by its conversion to 7‐OH mitragynine	46
Supersulfide biology and translational medicine for disease control	46
Decoding fatal toxic effects in checkpoint inhibitor therapy using real‐world pharmacovigilance data and machine learning	45
GPR84 in physiology—Many functions in many tissues	44
Deferiprone attenuates neuropathology and improves outcome following traumatic brain injury	43
The Concise Guide to PHARMACOLOGY 2025/26: Catalytic receptors	41
Pharmacological inhibition of hydroxysteroid 11‐beta dehydrogenase type 1 (11‐βHSD1) after myocardial infarction preserves cardiac function in a translational mini‐pig model	41
Issue Information	40
RGS6 negatively regulates inhibitory G protein signaling in dopamine neurons and positively regulates binge‐like alcohol consumption in mice	39
Development of new Kir2.1 channel openers from propafenone analogues	39
	38
Targeting mitochondrial proteases for therapy of acute myeloid leukaemia	37
Semax peptide targets the μ opioid receptor gene Oprm1 to promote deubiquitination and functional recovery after spinal cord injury in female mice	37
Evidence generation throughout paediatric medicines life cycle: findings from collaborative work between European Medicines Agency (EMA) and EUnetHTA on use of extrapolation	37
In vitro and in vivo study of butyrylfentanyl and 4‐fluorobutyrylfentanyl in female and male mice: Role of the CRF1 receptor in cardiorespiratory impairment	37
Mineralocorticoid receptors in non‐alcoholic fatty liver disease	37
Glucose‐dependent insulinotropic polypeptide receptor antagonist treatment causes a reduction in weight gain in ovariectomised high fat diet‐fed mice	36
Elucidating the beneficial impact of exercise on chronic obstructive pulmonary disease and its comorbidities: Integrating proteomic and immunological insights	35
Discovery of alantolactone as a naturally occurring NLRP3 inhibitor to alleviate NLRP3‐driven inflammatory diseases in mice	35
Niclosamide prodrug enhances oral bioavailability and efficacy against hepatocellular carcinoma by targeting vasorin‐TGFβ signalling	35
Exploring effects of chronic d ‐cycloserine administration on expression of GluN2 subunits and tripartite synaptic transmission in thalamocortical pa	35
Identification of a human blood biomarker of pharmacological 11β‐hydroxysteroid dehydrogenase 1 inhibition	35
Nitric oxide and thiols: Chemical biology, signalling paradigms and vascular therapeutic potential	34
Insight in article retractions inBritish Journal of Pharmacologybetween the years 2000–2023. Implications for reducing fraud‐containing articles	34
Macrocyclic diterpenoids from Stellera chamaejasme roots alleviate imiquimod‐induced psoriasiform inflammation via STAT1/S100A9 signalling pathway	33
Potential medicinal value of N6‐methyladenosine in autoimmune diseases and tumours	32
Defining and unpacking the core concepts of pharmacology: A global initiative	32
From mundane to classic: Sinomenine as a multi‐therapeutic agent	31
Site‐specific m6A‐miR‐494‐3p, not unmethylated miR‐494‐3p, compromises blood brain barrier by targeting tight junction protein 1 in intracranial atherosclerosis	31
tiRNA‐Gly‐GCC‐002 promotes epithelial‐mesenchymal transition and fibrosis in lupus nephritis via FKBP5‐mediated activation of Smad	31
Combination therapy enhances efficacy and overcomes toxicity of metal‐based anti‐diabetic agent	31
Bioactivity‐based molecular networking‐guided identification of guttiferone J from Garcinia cambogia as an anti‐obesity candidate	31
Intravenous recombinant cerebellin 1 treatment restores signalling by spinal glutamate delta 1 receptors and mitigates chronic pain	30
Network‐based precision medicine and systems pharmacology	30
β‐Arrestin‐biased proteinase‐activated receptor‐2 antagonist C781 limits allergen‐induced airway hyperresponsiveness and inflammation	30
Sevoflurane acts as an antidepressant by suppression of GluN2D‐containing NMDA receptors on interneurons	30
Targeting accelerated pulmonary ageing to treat chronic obstructive pulmonary disease‐induced neuropathological comorbidities	29
Silibinin, a commonly used therapeutic agent for non‐alcohol fatty liver disease, functions through upregulating intestinal expression of fibroblast growth factor 15/19	29
Targeting cluster of differentiation 26 / dipeptidyl peptidase 4 (CD26/DPP4) in organ fibrosis	29
The Concise Guide to PHARMACOLOGY 2025/26: G protein‐coupled receptors	29

Fifty years with aspirin and platelets	28
Airway delivery of Streptococcus salivarius is sufficient to induce experimental pulmonary hypertension in rats	28
The role of venous capacity in fluid retention with endothelin A antagonism: Mathematical modelling of the RADAR trial	28
NRF2 signalling in cytoprotection and metabolism	28
	27
Issue Information	27
Issue Information	27
	27
	27
Efficacy in diet‐induced obese mice of the hepatotropic, peripheral cannabinoid 1 receptor inverse agonist TM38837	27
Perspective article: A proposal for rational drug class terminology	26
Gαq signalling from endosomes: A new conundrum	26
A proposal for rational drug class terminology: A gastrointestinal perspective	26
Autocrine activation of P2X7 receptors mediates catecholamine secretion in chromaffin cells	25
AMP‐activated protein kinase in the amygdala and hippocampus contributes to enhanced fear memory in diabetic mice	25
	25
	25
Preclinical models for evaluating psychedelics in the treatment of major depressive disorder	25
Nicotinic‐acid derivative BGP‐15 improves diastolic function in a rabbit model of atherosclerotic cardiomyopathy	25
BQ788 reveals glial ETB receptor modulation of neuronal cholinergic and nitrergic pathways to inhibit intestinal motility: Linked to postoperative ileus	24
Increased expression of the ATP‐gated P2X7 receptor reduces responsiveness to anti‐convulsants during status epilepticus in mice	24
A high‐precision view of intercompartmental drug transport via simultaneous, seconds‐resolved, in situ measurements in the vein and brain	24
Ligand bias and inverse agonism on 5‐HT2A receptor‐mediated modulation of G protein activity in post‐mortem human brain	24
Oxidized soluble guanylyl cyclase causes erectile dysfunction in alcoholic mice	24
Differential regulation of Cav3.2 and Cav2.2 calcium channels by CB1 receptors and cannabidiol	24
Pharmacological profiling of small molecule modulators of the TMEM16A channel and their implications for the control of artery and capillary function	24
Blood pressure‐independent renoprotective effects of small interference RNA targeting liver angiotensinogen in experimental diabetes	23
Cathepsins and SARS‐CoV‐2 infection: From pathogenic factors to potential therapeutic targets	23
Kinetic analysis of fluorescent ligand binding to cell surface receptors: Insights into conformational changes and allosterism in living cells	23
Effects of microsomal prostaglandin E synthase‐1 inhibition on resistance artery tone in patients with end stage kidney disease	23
Proteinase‐activated receptor‐2 antagonist C391 inhibits Alternaria‐induced airway epithelial signalling and asthma indicators in acute exposure mouse models	23
R2R01: A long‐acting single‐chain peptide agonist of RXFP1 for renal and cardiovascular diseases	22
Dual effects of mefenamic acid on the IKs molecular complex	22
The anti‐fibrotic effects of novel heart failure pharmacotherapies in advanced heart failure patients	22
Contribution of haemodynamic side effects and associated autonomic reflexes to ventricular arrhythmias triggering by torsadogenic hERG blocking drugs	22
QM107, a novel CD148 (RTP Type J) activating peptide therapy for treating neovascular age‐related macular degeneration	22
Cav1.3‐selective inhibitors of voltage‐gated L‐type Ca2+ channels: Fact or (still) fiction?	22
Pharmacodynamics of the orexin type 1 (OX1) receptor in colon cancer cell models: A two‐sided nature of antagonistic ligands resulting from partial dissociation of Gq	21
Central metabolism as a potential origin of sex differences in morphine antinociception but not induction of antinociceptive tolerance in mice	21
Natural products and cancer: From drug discovery to prevention and therapy	21
Bioavailability of flumequine and diclofenac in mice exposed to a metal‐drug chemical cocktail. Evaluation of the protective role of selenium.	21
Stabilisation of PRCP by deubiquitinase‐targeting chimera (DUBTAC) to replenish autophagy for ameliorating pathological cardiac hypertrophy	21
Carfentanil is a β‐arrestin‐biased agonist at the μ opioid receptor	21
Therapeutic effect of human ApoA‐I‐Milano variant in aged transgenic mouse model of Alzheimer's disease	20
A p75 neurotrophin receptor‐sparing nerve growth factor protects retinal ganglion cells from neurodegeneration by targeting microglia	20
Issue Information	20
Expression of Concern: Effects of Tyrphostins and Genistein on the Virculatory Gailure and Organ Dysfunction Caused by Endotoxin in the Rat: A Possible Role for Protein Tyrosine Kinase	20
Resolution pharmacology and the treatment of infectious diseases	20
Issue Information	20
Structural perspectives on the mechanism of signal activation, ligand selectivity and allosteric modulation in angiotensin receptors: IUPHAR Review 34	20
Methanobactin rapidly facilitates biliary copper excretion in a Wilson disease rat model visualised by 64 Cu PET/MRI	20
Ticagrelor increases its own potency at the P2Y12 receptor by directly changing the plasma membrane lipid order in platelets	20
Issue Information	20
Activating transcription factor‐3 orchestrates the modulation of vascular anti‐contractile activity and relaxation by governing the secretion of HDL‐bound sphingosine‐1‐phosphate in perivascular adipo	20
Resolution of inflammation in pulmonary arterial hypertension, the influence of sex—An IUPHAR immunopharmacology committee review	19
Linking drug and food addiction via compulsive appetite	19
Silencing the fibronectin gene (FN1) improves NaCl‐induced cardiac fibrosis via ferritinophagy‐mediated ferroptosis in a nuclear receptor coactivator 4 (NCOA4)‐dependent manner	19
The flavonoid GL‐V9 alleviates liver fibrosis by triggering senescence by regulating the transcription factor GATA4 in activated hepatic stellate cells	19
Stimulation of platelet P2Y 1 receptors by different endogenous nucleotides leads to functional selectivity via biased signalling	19
Compound 4a induces paraptosis in liver cancer through endoplasmic reticulum stress mediated by the calreticulin protein	19
EXPRESSION OF CONCERN: H2S‐Donating Sildenafil (ACS6) Inhibits Superoxide Formation and gp91phox Expression in Arterial Endothelial Cells: Role of Protein Kinases A and G	19
Sex‐specific impact of repeated adolescent vapour exposure to JWH‐018 on dopamine response, behaviour and pharmacokinetics across adolescence and adulthood	19
The adiponectin receptor agonist AdipoAI attenuates periodontitis in diabetic rats by inhibiting gingival fibroblast‐induced macrophage migration	19
Photochemical control of cold‐sensitive TRPA1 ion channel gating for modulation of pain sensation	19
Targeting noncoding RNAs to treat atherosclerosis	19
Novel agonist and antagonist radioligands for the GLP‐2 receptor. Useful tools for studies of basic GLP‐2 receptor pharmacology	19
Baclofen modulates the immune response after spinal cord injury with locomotor benefits	19
Airway epithelial overexpressed cathepsin K induces airway remodelling through epithelial–mesenchymal trophic unit activation in asthma	19
Activation of the pentose phosphate pathway flux by hydrogen peroxide is not regulated by NADPH‐mediated feedback inhibition	19
Advancing antihypertensive drug development	19
Substitution of the SERCA2 Cys674 reactive thiol accelerates atherosclerosis by inducing endoplasmic reticulum stress and inflammation	19
Enterolactone promotes efficacy of gemcitabine on epithelial ovarian cancer and ameliorates gut dysbacteriosis	18
The Concise Guide to PHARMACOLOGY 2025/26: Ion channels	18
Smooth muscle cell Piezo1 is essential for phenotypic switch and neointimal hyperplasia	18
A GLP‐1/glucagon (GCG)/CCK2 receptors tri‐agonist provides new therapy for obesity and diabetes	18
Issue Information	18
	18
Mucin‐fused myeloid‐derived growth factor (MYDGF164) exhibits a prolonged serum half‐life and alleviates fibrosis in chronic kidney disease	18
Increased heroin intake and relapse vulnerability in intermittent relative to continuous self‐administration: Sex differences in rats	18
Synergistic augmentation of rhythmic myogenic contractions of human stomach by arginine vasopressin and adrenaline: Implications for the induction of nausea	18

Formation and clearance of TNF–TNF inhibitor complexes during TNF inhibitor treatment	18
	18
	18
Safety Toxicology	18
Hydroxyl chalcone derivative DK02 as a multi‐target‐directed ligand for Alzheimer's disease: A preclinical study in zebrafish	18
Allicin ameliorates imiquimod‐induced psoriasis‐like skin inflammation via disturbing the interaction of keratinocytes with IL‐17A	18
A peptide rich in glycine–serine–alanine repeats ameliorates Alzheimer‐type neurodegeneration	18
Issue Information	18
	17
CircPTK2 enhances non‐small cell lung cancer proliferation by inhibiting cellular senescence through stabilizing NFYA and elevating FOXM1	17
Issue Information	17
Innovative pharmacotherapy for hepatic metabolic and chronic inflammatory diseases in China	17
Novel approaches for the discovery of pharmacogenetic biomarkers of chemotoxicity in patients with colorectal cancer	17
Corticosteroid insensitivity in asthma associated with obstructive sleep apnoea: Role of oxidative stress and histone acetylation	17
Mechanopharmacology	16
Unravelling the multifaceted actions of neurosteroids: Machine learning and in vitro screening for novel target discovery	16
V‐domain immunoglobulin suppressor of T‐cell activation and programmed death receptor 1 dual checkpoint blockade enhances antitumour immunity and survival in glioblastoma	16
Neutrophil β1 adrenoceptor blockade blunts stroke‐associated neuroinflammation	16
Bioactive ligands targeting ectopic olfactory receptors: Implications for therapeutic strategies	16
Vesicular glutamate transporter VGLUT2 expression emerges in substantia nigra dopamine neurons in mouse models of parkinsonism in the absence of neurodegeneration	16
Oral anticoagulants: A plausible new treatment for Alzheimer's disease?	16
Chemistry/structural biology of psychedelic drugs and their receptor(s)	16
Trilobatin attenuates cerebral ischaemia/reperfusion‐induced blood–brain barrier dysfunction by targeting matrix metalloproteinase 9: The legend of a food additive	16
Cannabinoid CB2 receptor‐mediated analgesia: mechanism‐based insights and therapeutic potential	16
Naringenin relieves paclitaxel‐induced pain by suppressing calcitonin gene‐related peptide signalling and enhances the anti‐tumour action of paclitaxel	16
Targeting acetylated high mobility group box 1 protein (HMGB1) and toll‐like receptor (TLR4) interaction to alleviate hypertension and neuroinflammation in fructose‐fed rats	16
Opioid receptors in cardiovascular function	16
Difluorinated thromboxane A2 reveals crosstalk between platelet activatory and inhibitory pathways by targeting both the TP and IP receptors	16
Isoxazole 9 (ISX9), a small molecule targeting Axin, activates Wnt/β‐catenin signalling and promotes hair regrowth	16
Targeting FDX1 by trilobatin to inhibit cuproptosis in doxorubicin‐induced cardiotoxicity	16
In silico , in vitro and ex vivo characterization of cystic fibrosis transmembrane conductance regulator pathogenic variants l	15
Natural Products	15
Issue Information	15
Disruption of survivin protein expression by treatment with YM155 accelerates the resolution of neutrophilic inflammation	15
Complement tunes glutamate release and supports synaptic impairments in an animal model of multiple sclerosis	15
Cannabinoid 1 (CB1) receptor arrestin subtype‐selectivity and phosphorylation dependence	15
Soluble epoxide hydrolase inhibition enhances production of specialized pro‐resolving lipid mediator and promotes macrophage plasticity	15
CORRECTION	15
RETRACTION: L6H21 protects against cognitive impairment and brain pathologies via toll‐like receptor 4–myeloid differentiation factor 2 Signalling in Prediabetic rats	15
	15
Cannabigerol reverses mechanical allodynia through α 2A ‐adrenergic modulation of thalamocortical signaling in chemotherapy‐induced neuropathy	15
Paraoxonase‐2 agonist vutiglabridin promotes autophagy activation and mitochondrial function to alleviate non‐alcoholic steatohepatitis	15
Assessment of the molecular mechanisms of drug‐induced hidden cardiotoxicity by a multi‐omics approach: The example of rofecoxib	15
A long‐acting FGF21 attenuates metabolic dysfunction‐associated steatohepatitis‐related fibrosis by modulating NR4A1‐mediated Ly6C phenotypic switch in macrophages	15
Issue Information	15
	15
	15
The Concise Guide to PHARMACOLOGY 2023/24: Transporters	15
The ion channel TRPM8 is a direct target of the immunosuppressant rapamycin in primary sensory neurons	15
Issue Information	14
EDITORIAL for BJP themed issue “noncoding RNA therapeutics”	14
A pH‐sensitive opioid does not exhibit analgesic tolerance in a mouse model of colonic inflammation	14
Galangin alleviates vitiligo by targeting ANXA2 degradation in macrophages	14
Adipose tissue as a therapeutic target for vascular damage in Alzheimer's disease	14
Pulmonary arterial hypertension: Sex matters	14
Genetic deletion or pharmacological blockade of nociceptin/orphanin FQ receptors in the ventral tegmental area attenuates nicotine‐motivated behaviour	14
Building Bridges In Neuropharmacology: New therapeutic approaches for psychiatric and neurodegenerative disorders	14
Commentary on ‘Identification and characterization of select oxysterols as ligands for GPR17’	14
Sarco/endoplasmic reticulum Ca2+‐ATPase (SERCA2b) mediates oxidation‐induced endoplasmic reticulum stress to regulate neuropathic pain	14
Explainable AI and debiased networks: The ‘last mile’ for precision medicine delivery	14
Clemastine attenuates subarachnoid haemorrhage pathology in a mouse model via Nrf2/SQSTM1‐mediated autophagy	14
Arbidol, an antiviral drug, identified as a sodium channel blocker with anticonvulsant activity	14
Butyrate acts as a positive allosteric modulator of the 5‐HT transporter to decrease availability of 5‐HT in the ileum	14
An antisense oligonucleotide targeting the heat‐shock protein HSPB5 as an innovative therapeutic approach in pulmonary fibrosis	14
Single cell G‐protein coupled receptor profiling of activated kidney fibroblasts expressing transcription factor 21	14
The Australia story: Current status and future challenges for the clinical applications of psychedelics	14
AMG487 alleviates influenza A (H1N1) virus‐induced pulmonary inflammation through decreasing IFN‐γ‐producing lymphocytes and IFN‐γ concentrations	14
Advancing Alzheimer's disease pharmacotherapy: efficacy of glucocorticoid modulation with dazucorilant (CORT113176) in preclinical mouse models	13
Novel non‐steroidal mineralocorticoid receptor antagonists in cardiorenal disease	13
Ibuprofen inhibits human sweet taste and glucose detection implicating an additional mechanism of metabolic disease risk reduction	13
Correction to “Deletion of AMPKα1 attenuates the anticontractile effect of perivascular adipose tissue (PVAT) and reduces adioponectin release”	13
ApTOLL: A new therapeutic aptamer for cytoprotection and (re)myelination after multiple sclerosis	13
Pathogenic roles of neutrophil‐derived alarmins (S100A8/A9) in heart failure: From molecular mechanisms to therapeutic insights	13
No new ‘mabs’ in medicine—New nomenclature for monoclonal antibodies	13
Asthma and inflammation transcriptionally up‐regulate the aryl hydrocarbon receptor in airway smooth muscle via p38/JNK‐AP1 signalling	13
	13
Issue Information	13
Cell‐based therapy for diabetic cardiovascular complications: Prospects and challenges	13
To CB2 or not CB2: Revisiting renoprotection in acute and chronic kidney injury	13
Issue Information	13
Issue Information	13
	13
A comment on the interpretation of ligand binding experiments for agonists	13
Time‐dependent dual effect of NLRP3 inflammasome in brain ischaemia	13
Ginsenosides retard atherogenesis via remodelling host–microbiome metabolic homeostasis	13
	13
Non‐canonical PKG1 regulation in cardiovascular health and disease	13
Genetic polymorphisms influencing antihypertensive drug responses	12
Molecular dynamic and pharmacological studies on protein‐engineered hirudin variants of Hirudinaria manillensis and Hirudo medicinalis	12
Sub‐chronic administration of AM6545 enhances cognitive performance and induces hippocampal synaptic plasticity changes in naïve mice	12
The opioid partial agonist PPL‐138 reduces alcohol self‐administration in rats susceptible to post‐traumatic stress disorder	12
Bias translation: The final frontier?	12
Blockade of TMEM16A protects against renal fibrosis by reducing intracellular Cl− concentration	12
SEW2871 attenuates myocyte necroptosis in heart failure through inhibition of oxidative stress and inflammatory cytokines	12
Improving K v 7 targeting anticonvulsants ‐ will repurposing save the day?	12